TABLE 2.
Clinical Features | |
---|---|
| |
Age* (yr), mean ± SD | 55.6 ± 23.9 |
Female sex,† n (%) | 20 (38.5) |
Lesion location,‡ n (%) | |
Trunk | 19 (33.3) |
Visceral metastases | 6 (10.5) |
Small bowel | 4 |
Lung | 2 |
Head/neck | 15 (26.3) |
Upper extremity | 9 (15.8) |
Lower extremity | 8 (14.0) |
Histopathologic features | |
Primary lesion size (cm), mean ± SD (range) | 1.4 ± 1.3 (0.3–6.5) |
Lesion classification | |
Benign nevus, n (%) | 8 (14.0) |
Borderline lesion, n (%) | 16 (28.1) |
Atypical Spitz tumor | 8 |
Atypical nevus | 6 |
Combined epithelioid melanocytoma associated with a nevus | 1 |
Conventional nevus combined with an atypical Spitz nevus | 1 |
Primary melanoma, n (%) | 22 (38.6) |
Not otherwise specified | 6 |
Nodular | 5 |
Superficial spreading | 4 |
Nevoid | 2 |
Spitzoid melanoma in situ | 1 |
Superficial spreading and spindle cell | 1 |
Dedifferentiated and spindled | 1 |
Mixed spindled and desmoplastic | 1 |
Melanoma in situ | 1 |
Metastatic melanoma, n (%) | 11 (19.3) |
Breslow depth§ (mm), mean ± SD (range) | 4.6 ± 4.2 (0.8–21.0) |
At the time of biopsy.
n = 52 patients.
n = 57 lesions.
Of confirmed primary melanomas (n = 22).